CHARDONNET LAURENTother: Vice President and Treasurerother: Vice President and Treas..
Common Stock
13,976
$22.7
$317,255
Option
LEVY RICHARD Sofficer: EVP, Chief Drug Dev Officerofficer: EVP, Chief Drug Dev Of..
Common Stock
30,000
$8.72
$261,690
Sale
LEVY RICHARD Sofficer: EVP, Chief Drug Dev Officerofficer: EVP, Chief Drug Dev Of..
Common Stock
30,000
$22.95
$688,500
Option
LEVY RICHARD Sofficer: EVP, Chief Drug Dev Officerofficer: EVP, Chief Drug Dev Of..
Incentive Stock Option (right to buy)
11,809
$8.99
$106,163
Option
LEVY RICHARD Sofficer: EVP, Chief Drug Dev Officerofficer: EVP, Chief Drug Dev Of..
Non-Qualified Stock Option (right to buy)
9,751
$8.99
$87,661
Option
WHITFIELD ROY Adirectordirector
Common Stock
14,000
$4.15
$58,100
Option
WHITFIELD ROY Adirectordirector
Non-Qualified Stock option (right to buy)
4,000
$3.86
$15,440
Option
WHITFIELD ROY Adirectordirector
Non-Qualified Stock option (right to buy)
36,000
$3.33
$119,880
Option
WHITFIELD ROY Adirectordirector
Common Stock
36,000
$3.33
$119,880
Sale
WHITFIELD ROY Adirectordirector
Common Stock
20,000
$17.53
$350,600
Option
DE SCHUTTER RICHARD Udirector, other: Chairmandirector, other: Chairman
Non-Qualified Stock Option (right to buy)
20,000
$7.68
$153,600
Option
DE SCHUTTER RICHARD Udirector, other: Chairmandirector, other: Chairman
Common Stock
65,000
$7.43
$482,625
Purchase
BROOKE PAUL Adirectordirector
Common Stock
25,000
$17.86
$446,500
Purchase
BROOKE PAUL Adirectordirector
Common Stock
25,000
$17.86
$446,500
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
5,856
$16.55
$96,929
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
217,511
$16.55
$3,600,242
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
325,728
$16.29
$5,307,412
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
8,769
$16.29
$142,882
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
181,201
$13.23
$2,396,383
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
4,862
$13.23
$64,300
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
5,965
$13.45
$80,253
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
222,320
$13.45
$2,991,093
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
144,903
$13.22
$1,915,328
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
3,878
$13.22
$51,259
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
338,406
$13.53
$4,578,633
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
9,057
$13.53
$122,541
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
28,685
$13.88
$398,176
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
1,071,825
$13.88
$14,878,003
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
828,622
$14.11
$11,687,713
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
22,380
$14.11
$315,670
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
507,911
$13.44
$6,828,355
Purchase
14159 CAPITAL (GP), LLCdirector, 10 percent ownerdirector, 10 percent owner
Common Stock
28,890
$12.21
$352,776
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLCdirector, 1..director, 10 percent owner
Common Stock
1,069,646
$12.21
$13,061,447
Purchase
DIXON WENDY Ldirectordirector
Common Stock
7,500
$13.39
$100,448
Purchase
DE SCHUTTER RICHARD Udirector, other: Chairmandirector, other: Chairman
4.75% Convertible Senior Notes due 2015
225,000
$8.78
$1,975,500
Option
CHARDONNET LAURENTother: Vice President and Treasurerother: Vice President and Treas..
Non-Qualified Stock Option (right to buy)
29,165
$5.46
$159,241
Option
CHARDONNET LAURENTother: Vice President and Treasurerother: Vice President and Treas..
Common Stock
40,000
$5.46
$218,400
Sale
CHARDONNET LAURENTother: Vice President and Treasurerother: Vice President and Treas..
Common Stock
40,000
$18.65
$746,160
Sale
WHITFIELD ROY Adirectordirector
Common Stock
15,498
$18.04
$279,584
Sale
WHITFIELD ROY Adirectordirector
Common Stock
4,502
$18.03
$81,180
Option
HASTINGS DAVID Cofficer: Chief Financial Officerofficer: Chief Financial Officer
Incentive Stock Option (right to buy)
18,124
N/A
N/A
Option
HASTINGS DAVID Cofficer: Chief Financial Officerofficer: Chief Financial Officer
Common Stock
100,000
$5.12
$512,000
Option
HASTINGS DAVID Cofficer: Chief Financial Officerofficer: Chief Financial Officer
Non Qualified Stock Option (right to buy)
81,876
$5.12
$419,205
Sale
HASTINGS DAVID Cofficer: Chief Financial Officerofficer: Chief Financial Officer
Common Stock
100,000
$17.76
$1,776,000
Option
SWAIN PAULA Jofficer: EVP, Human Resourcesofficer: EVP, Human Resources
Common Stock
75,000
$13.8
$1,035,000
Option
SWAIN PAULA Jofficer: EVP, Human Resourcesofficer: EVP, Human Resources
Non-Qualified Stock Option
51,699
$13.8
$713,446
Sale
SWAIN PAULA Jofficer: EVP, Human Resourcesofficer: EVP, Human Resources
Common Stock
75,000
$19.3
$1,447,500
Sale
WHITFIELD ROY Adirectordirector
Common Stock
10,000
$20.31
$203,060
Sale
WHITFIELD ROY Adirectordirector
Common Stock
10,000
$20.02
$200,200
Showing 1000 to 1050 of 1431 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.